Novel Approaches to 7-transmembrane Receptor Therapeutics

Venue: 7 World Trade Center

Location: New York, New York, United States

Event Date/Time: Sep 23, 2008
Registration Date: Sep 23, 2008
Report as Spam


G protein-coupled receptors (GPCRs) are high impact therapeutic targets, constituting 50% of drug targets and generating annual drug sales above 50 billion dollars (Lundstrom K, 2006). Historically, most drug discovery campaigns have sought to identify compounds that specifically activate the receptor (agonists), or block activation by an endogenous compound (antagonist), both via a G-protein dependent signaling pathway.

The BPDG at the New York Academy of Sciences represents a diverse group of scientists and others with an interest in biochemistry, molecular biology, biomedical research, and related areas. Members are from pharmaceutical and biotechnology companies, and university and medical center research facilities across the Eastern United States. The group also serves as the Biochemical Topical Group for the American Chemical Society's New York Section. The purpose of the BPDG is to bring together diverse institutions and communities, industrial and academic, to share new and relevant information at the frontiers of research and development.


250 Greenwich St. 40th FL
New York
New York
United States